PCSK9 and cancer: This analysis also implies that Pep2-8 may inhibit cell death and apoptosis in tumor/cancer cells, indicating that PCSK9 inhibition may provide benefit to vascular aging but potentially predisposing to neoplasms, a possibility that will require careful evaluation.